IUD and Depression Risk
Levonorgestrel-releasing IUDs (LNG-IUDs) are associated with an increased risk of depression, particularly in adolescents and young women using them as their first hormonal contraceptive, with the highest quality recent evidence showing a 57% increased risk overall and up to 157% increased risk in adolescent users.
Evidence Quality and Strength
The most robust and recent evidence comes from a 2023 Swedish national register-based cohort study of over 703,000 women aged 15-24 1. This large-scale population study found:
- Overall increased depression risk: 57% (AHR 1.57,95% CI 1.51-1.64)
- Adolescent users: 157% increased risk (AHR 2.57,95% CI 2.36-2.80)
- First-time hormonal contraceptive users: 63% increased risk (AHR 1.63,95% CI 1.50-1.78)
A 2023 systematic review corroborates these findings, with 10 studies showing increased depressive symptoms and additional evidence of anxiety and suicidal ideation 2.
Contradictory Evidence
Older evidence from 2018 presents conflicting conclusions:
- A systematic review of progestin-only methods found minimal association with depression, with 4 out of 5 LNG-IUD studies showing no correlation 3
- A UK cohort study found associations with anxiety (HR 1.18) and sleep problems (HR 1.22) but focused less on depression 4
The key difference: The 2023 Swedish study is substantially larger, more recent, and specifically examined young women—the highest-risk population.
Critical Risk Factors to Assess
Before prescribing LNG-IUDs, identify high-risk patients:
- Age < 25 years (especially adolescents 15-19)
- No prior hormonal contraceptive use
- Personal or family history of depression/psychiatric disorders
- Current depressive symptoms or anxiety
Clinical Algorithm
For adolescents and young women (age 15-24):
- Conduct psychiatric screening before insertion
- Counsel explicitly about 2.5-fold increased depression risk
- Consider copper IUD as alternative (no hormonal effects)
- If LNG-IUD chosen, schedule follow-up at 3 months for mood assessment
For women ≥25 years with no psychiatric history:
- Standard counseling about potential mood effects
- Routine monitoring acceptable
For women with psychiatric history at any age:
- Strongly consider non-hormonal alternatives (copper IUD)
- If LNG-IUD used, establish close psychiatric monitoring
- Counsel about increased risk of anxiety and sleep disturbances 4
Important Caveats
The 2023 Swedish study noted that risk estimates decreased over the study period as LNG-IUDs became more accessible to nulliparous women, suggesting possible confounding by indication—meaning women with pre-existing vulnerabilities may have been selectively prescribed LNG-IUDs 1. A 2026 qualitative study confirms this practice, showing healthcare professionals particularly promote LNG-IUDs to "vulnerable" adolescents 5, which could artificially inflate risk associations.
However, this confounding does not eliminate the clinical concern—it actually reinforces that certain populations are at higher risk and require careful monitoring.
Monitoring and Management
If depression develops after LNG-IUD insertion:
- Remove device if patient desires (patient autonomy is paramount per 2024 CDC guidelines 6)
- Offer alternative contraception immediately
- Refer for psychiatric evaluation if symptoms are moderate-severe
- Document temporal relationship between insertion and symptom onset
Mandatory counseling points:
- Depression risk exists, particularly in young users
- Symptoms may include depressed mood, anxiety, sleep problems, and in rare cases, suicidal ideation 2
- Patient should contact provider immediately if mood changes occur
- Removal is always an option
The 2024 CDC guidelines emphasize patient autonomy: if a patient desires removal at any time due to side effects, remove the device and offer counseling on alternatives 6.